Marlio Charles Mosseri - 17 Jun 2025 Form 4 Insider Report for Nuvectis Pharma, Inc. (NVCT)

Role
10%+ Owner
Signature
/s/ Charles Mosseri-Marlio
Issuer symbol
NVCT
Transactions as of
17 Jun 2025
Net transactions value
+$269,532
Form type
4
Filing time
20 Jun 2025, 09:50:29 UTC
Previous filing
13 May 2025
Next filing
24 Jun 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Mosseri Marlio Charles 10%+ Owner 27 RIPPLEVALE GROVE, LONDON, LIBYAN ARAB JAMAHIRIYA /s/ Charles Mosseri-Marlio 20 Jun 2025 0001806384

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NVCT Common Stock Purchase $43,786 +5,399 +0.18% $8.11 2,948,160 17 Jun 2025 By Emerald Hill Ventures SARL SPF. F1
transaction NVCT Common Stock Purchase $225,746 +28,043 +0.95% $8.05 2,976,203 18 Jun 2025 By Emerald Hill Ventures SARL SPF. F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.
F2 Reflects the weighted average purchase price. The range of prices for the shares purchased was $7.91 to $8.11. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.